TY - JOUR
T1 - 2D Materials for Combination Therapy to Address Challenges in the Treatment of Cancer
AU - Self, Ava
AU - Farell, Megan
AU - Samineni, Laximicharan
AU - Kumar, Manish
AU - Gomez, Esther W.
N1 - Publisher Copyright:
© 2023 The Authors. Advanced NanoBiomed Research published by Wiley-VCH GmbH.
PY - 2023/12
Y1 - 2023/12
N2 - 2D materials exhibit a variety of characteristics that make them appealing platforms for cancer treatment such as high drug loading capacity and photothermal and photodynamic properties. A key advantage of 2D material platforms for oncological applications is the ability to harness multiple modalities including drug delivery, photothermal therapy, photodynamic therapy, chemodynamic therapy, gene delivery, and immunotherapy approaches for improved efficacy. In this review, a comparison of the unique properties of different classes of 2D materials that enable their usage as platforms for multimodal therapy is provided. Further, the benefits and drawbacks of different platforms are also highlighted. Finally, current challenges and emerging opportunities for future development of 2D materials to further enable combination therapy and translation from the bench to clinical oncology applications are discussed.
AB - 2D materials exhibit a variety of characteristics that make them appealing platforms for cancer treatment such as high drug loading capacity and photothermal and photodynamic properties. A key advantage of 2D material platforms for oncological applications is the ability to harness multiple modalities including drug delivery, photothermal therapy, photodynamic therapy, chemodynamic therapy, gene delivery, and immunotherapy approaches for improved efficacy. In this review, a comparison of the unique properties of different classes of 2D materials that enable their usage as platforms for multimodal therapy is provided. Further, the benefits and drawbacks of different platforms are also highlighted. Finally, current challenges and emerging opportunities for future development of 2D materials to further enable combination therapy and translation from the bench to clinical oncology applications are discussed.
UR - http://www.scopus.com/inward/record.url?scp=85177765318&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85177765318&partnerID=8YFLogxK
U2 - 10.1002/anbr.202300070
DO - 10.1002/anbr.202300070
M3 - Review article
AN - SCOPUS:85177765318
SN - 2699-9307
VL - 3
JO - Advanced NanoBiomed Research
JF - Advanced NanoBiomed Research
IS - 12
M1 - 2300070
ER -